Acute Lymphoblastic Leukemia (ALL)
Showing NaN - NaN of 7
Acute Lymphoblastic Leukemia (ALL) Trial in United States (Vincristine Sulfate Liposomes Injection (VSLI), Vincristine Sulfate
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- Vincristine Sulfate Liposomes Injection (VSLI)
- Vincristine Sulfate Injection (VSI)
-
La Jolla, California
- +14 more
Sep 6, 2021
Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))
Completed
- Acute Lymphoblastic Leukemia (ALL)
- Marqibo® (vincristine sulfate liposomes injection)
-
Los Angeles, California
- +32 more
Feb 8, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®
Active, not recruiting
- Hematological Malignancies
- +6 more
- NiCord® (omidubicel)
- Cord Blood Unit
-
Los Angeles, California
- +51 more
Jan 7, 2021
Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)
Completed
- Hematological Malignancies
- +3 more
-
Los Angeles, California
- +14 more
Oct 1, 2020
For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States
Terminated
- For Donors
- +9 more
- CDX-301
- CDX-301 and plerixafor
-
Los Angeles, California
- +7 more
Apr 6, 2017
Acute Lymphoblastic Leukemia (ALL) Trial in United States (Moxetumomab Pasudotox)
Terminated
- Acute Lymphoblastic Leukemia (ALL)
- Moxetumomab Pasudotox
-
Los Angeles, California
- +3 more
Sep 15, 2015